Anzeige
Erschienen in:
19.06.2019 | Pelvis
Validation of SE-EPI-based T2 mapping for characterization of prostate cancer: a new method compared with the traditional CPMG method
Erschienen in: Abdominal Radiology | Ausgabe 10/2019
Einloggen, um Zugang zu erhaltenAbstract
Purpose
We aim to compare the results of spin echo–echo planar imaging (SE-EPI)-based T2 mapping with those of the conventional Carr–Purcell–Meiboom–Gill (CPMG) method and to investigate the potential validity of SE-EPI-T2 mapping for the characterization of prostate cancer (PCa).
Methods
Our retrospective study included 42 PCa patients and 42 noncancer patients who underwent 3.0T MRI with b values ranging from 0 to 2000 s/mm2 and echo times (TEs) ranging from 32 to 100 ms before biopsies. Bland–Altman analysis was used to compare the agreement between the two methods. The correlations between CPMG-T2 values and SE-EPI-T2 values at different b values were determined by Spearman’s rho analysis or Pearson analysis. The Mann–Whitney U test and two-sample t tests were used to analyze the differences between the cancerous and noncancerous groups.
Results
Substantial agreement regarding the measurements was observed between the two methods. The average correlation between the CPMG-T2 values and SE-EPI-T2 values was moderate and positive, and the best correlations were found at b = 200 s/mm2 in the noncancer group (r = 0.557, P = 0.000) and at b = 100 s/mm2 in the cancer group (r = 0.537, P = 0.000). In addition, statistically significant differences were found between the noncancer and cancer groups in T2 values and ADC values (diff TEs) (P = 0.000).
Conclusions
Substantial agreement in the measurements was found between the SE-EPI method and CPMG method. SE-EPI-based T2 mapping has potential clinical value for the prostate and can be considered an alternative to the traditional CPMG-T2 mapping method.